Tecovirimat monohydrate is used to treat human smallpox and is also used on an expanded access basis for monkeypox (mpox) and disseminated vaccinia virus infections, as well as complications that can arise from smallpox vaccination. It is an antiviral medication that works by blocking the release of viral particles from infected cells. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Tecovirimat hydrate and ST-246 monohydrate. Its PubChem CID is 90479083.
Tecovirimat monohydrate
| CAS No | 1162664-19-8 |
|---|---|
| Molecular Formula | C19H17F3N2O4 |
| Molecular Weight | 394.3 g/mol |
| Synonyms | N-[(1S,2S,6R,7R,8R,10S)-3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide;hydrate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tecovirimat monohydrate is used to treat human smallpox and is also used on an expanded access basis for monkeypox (mpox) and disseminated vaccinia virus infections, as well as complications that can arise from smallpox vaccination.
The listed CAS number is 1162664-19-8.
The listed molecular formula is C19H17F3N2O4.
The listed molecular weight is 394.3 g/mol.
N-[(1S,2S,6R,7R,8R,10S)-3,5-dioxo-4-azatetracyclo[5.3.2.02,6.08,10]dodec-11-en-4-yl]-4-(trifluoromethyl)benzamide;hydrate.
The source lists Tecovirimat hydrate and ST-246 monohydrate.